Biggest News Aggregation in the World
๐Ÿ“ฐ Patient Reported News

Patient Reported News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Patient Reported. Real-time updates on events, politics, business and more.

"Assessing Patient-Reported Outcomes in Routine Cancer Clinical Care Us" by Ramkumar Govindaraj, Meera Agar et al.

BACKGROUND: The routine measurement of patient-reported outcomes in cancer clinical care using electronic patient-reported outcome measures (ePROMs) is gaining momentum worldwide. However, a deep understanding of the mechanisms underpinning ePROM interventions that could inform their optimal design to improve health outcomes is needed. OBJECTIVE: This study aims to identify the implicit mechanisms that underpin the effectiveness of ePROM interventions and develop program theories about how and w...
Ovid Embase Mixed Methods Appraisal Lectronic Patient Reported Outcome Measure Literature Review Mobile Phone Narrative Review
Source: uow.edu.au

Astellas' Fezolinetant Reduces Frequency and Severity of VMS Associated with Menopause in Women Considered Unsuitable for Hormone Therapy

Phase 3b DAYLIGHT study being presented at ESG 2023 demonstrated fezolinetant 45 mg achieved statistically significant reductions in the frequency and severity of moderate to severe vasomotor symptoms due to menopause and patient-reported sleep disturbance at 24 weeks Women considered unsuitable included those with contraindications, who are averse to taking, have stopped taking or have conditions that suggest caution in using hormone therapy Results will support health technology a...
Noord Holland Rossella Nappi Naoki Okamura San Matteo Foundation University Of Pavia European Society Of Gynecology

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Bristol Myers Squibb Presents New Data at Digestive Disease Week® on Zeposia (ozanimod) Highlighting Clinical Benefits and Safety Profile in Patients with Ulcerative Colitis

Bristol Myers Squibb (NYSE:BMY) today announced that additional data from multiple studies evaluating Zeposia (ozanimod) in ulcerative colitis (UC) were presented at Digestive Disease Week ร‚ยฎ (DDW), taking place virtually May 21-23, 2021. These data deepen the understanding of Zeposia and reinforce Bristol Myers Squibbรขย€ย™s commitment to understanding and addressing unmet needs in gastroenterology. Research being shared includes: Safety of Ozanimod in Patients with Moderately to Severely ...
United States Mary Beth Harler Bristol Myers Squibb American Society For Gastrointestinal Endoscopy Bristol Myers Squibb Company Health Economics

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science